CAH - Cardinal Health Inc Stock Price, Fair Value and News

106.47USD-0.70 (-0.65%)Market Closed

Market Summary

USD106.47-0.70

Market Closed

-0.65%

CAH Stock Price

View Fullscreen

CAH RSI Chart

CAH Valuation

Market Cap

25.9B

Price/Earnings (Trailing)

40.53

Price/Sales (Trailing)

0.12

EV/EBITDA

13.13

Price/Free Cashflow

7.57

CAH Price/Sales (Trailing)

CAH Profitability

EBT Margin

0.52%

Return on Equity

23.42%

Return on Assets

1.37%

Free Cashflow Yield

13.21%

CAH Fundamentals

CAH Revenue

Revenue (TTM)

216.1B

Rev. Growth (Yr)

11.61%

Rev. Growth (Qtr)

4.9%

CAH Earnings

Earnings (TTM)

639.0M

Earnings Growth (Yr)

371.54%

Earnings Growth (Qtr)

7.0K%

Breaking Down CAH Revenue

Last 7 days

-1.4%

Last 30 days

-3.3%

Last 90 days

0.1%

Trailing 12 Months

34.0%

How does CAH drawdown profile look like?

CAH Financial Health

Current Ratio

0.98

Debt/Equity

1.3

Debt/Cashflow

1.12

CAH Investor Care

Dividend Yield

1.87%

Dividend/Share (TTM)

1.99

Buy Backs (1Y)

5.59%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	198.7B	205.0B	210.2B	216.1B
2022	176.8B	181.4B	187.0B	193.0B
2021	156.6B	162.5B	167.4B	171.3B
2020	153.6B	152.9B	154.6B	156.5B
2019	143.5B	145.5B	147.7B	149.7B
2018	134.4B	136.8B	139.4B	141.9B
2017	128.4B	130.0B	130.6B	132.6B
2016	117.7B	121.5B	125.5B	127.2B
2015	97.9B	102.5B	106.5B	112.4B
2014	93.6B	91.1B	90.6B	93.9B
2013	102.4B	101.1B	99.7B	96.7B
2012	107.6B	107.6B	106.6B	104.8B
2011	100.3B	102.6B	105.0B	106.7B
2010	98.4B	98.5B	98.2B	98.6B
2009	93.8B	96.0B	97.3B	98.1B
2008	0	87.4B	89.6B	91.7B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Cardinal Health Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 15, 2024	greene michelle d.	sold (taxes)	-72,993	109	-664	chief information officer
Mar 15, 2024	azelby robert	acquired	-	-	1,288	-
Feb 15, 2024	alt aaron e	sold (taxes)	-198,712	103	-1,919	chief financial officer
Feb 15, 2024	greene michelle d.	sold (taxes)	-68,757	103	-664	chief information officer
Dec 01, 2023	weitzman deborah	sold (taxes)	-68,317	107	-638	ceo, pharmaceutical segment
Dec 01, 2023	snow ola m	sold (taxes)	-40,904	107	-382	chief human resources officer
Dec 01, 2023	scherer mary c.	sold (taxes)	-23,236	107	-217	chief accounting officer
Nov 27, 2023	weitzman deborah	acquired	2,048,360	74.103	27,642	ceo, pharmaceutical segment
Nov 27, 2023	weitzman deborah	sold	-3,895,410	106	-36,642	ceo, pharmaceutical segment
Nov 15, 2023	hall patricia hemingway	acquired	-	-	1,965	-

Which funds bought or sold CAH recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 16, 2024	Buckley Wealth Management, LLC	reduced	-2.51	94,004	1,237,260	0.40%
Apr 16, 2024	Asset Dedication, LLC	unchanged	-	3,000	36,000	-%
Apr 16, 2024	Trifecta Capital Advisors, LLC	unchanged	-	222	2,238	-%
Apr 16, 2024	Transform Wealth, LLC	added	2.64	365,363	2,996,520	0.28%
Apr 16, 2024	Indiana Trust & Investment Management CO	unchanged	-	433	4,364	-%
Apr 16, 2024	Norwood Financial Corp	reduced	-9.75	341	181,277	0.26%
Apr 16, 2024	Kathmere Capital Management, LLC	reduced	-1.77	39,624	477,701	0.06%
Apr 16, 2024	FLAGSHIP HARBOR ADVISORS, LLC	added	50.65	224,369	558,143	0.04%
Apr 16, 2024	Perpetual Ltd	unchanged	-	78,932	795,721	0.01%
Apr 16, 2024	Artemis Investment Management LLP	reduced	-31.23	-2,752,870	8,860,530	0.11%

Are Funds Buying or Selling CAH?

Are funds buying CAH calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own CAH

No. of Funds

Unveiling Cardinal Health Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	12.69%	31,266,013	SC 13G/A
Jan 30, 2024	state street corp	5.90%	14,540,655	SC 13G/A
Jan 24, 2024	blackrock inc.	10.6%	26,152,886	SC 13G/A
Feb 14, 2023	price t rowe associates inc /md/	1.9%	4,994,087	SC 13G/A
Feb 09, 2023	vanguard group inc	11.95%	31,320,204	SC 13G/A
Feb 06, 2023	state street corp	6.70%	17,568,683	SC 13G/A
Jan 26, 2023	blackrock inc.	11.3%	29,572,939	SC 13G/A
Jan 20, 2023	blackrock inc.	11.3%	29,572,939	SC 13G/A
Sep 08, 2022	blackrock inc.	10.6%	28,946,151	SC 13G
Feb 14, 2022	price t rowe associates inc /md/	5.3%	15,028,767	SC 13G

Recent SEC filings of Cardinal Health Inc

View All Filings

Date Filed	Form Type	Document
Mar 18, 2024	4	Insider Trading
Mar 18, 2024	4	Insider Trading
Mar 01, 2024	3	Insider Trading
Feb 28, 2024	8-K	Current Report
Feb 20, 2024	8-K	Current Report
Feb 16, 2024	424B5	Prospectus Filed
Feb 16, 2024	4	Insider Trading
Feb 16, 2024	4	Insider Trading
Feb 14, 2024	FWP	Prospectus Filed
Feb 14, 2024	424B5	Prospectus Filed

Peers (Alternatives to Cardinal Health Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	183.7B	40.1B	-5.83%	1.66%	32.1	4.58	-8.12%	-17.45%
BDX	67.1B	19.5B	-2.32%	-8.43%	53.41	3.44	4.02%	-22.04%
ALGN	22.6B	3.9B	-4.99%	-13.70%	50.69	5.84	3.42%	23.09%
BAX	20.1B	14.8B	-4.86%	-7.71%	7.56	1.35	2.12%	209.17%
MID-CAP
ATR	9.1B	3.5B	-0.64%	16.68%	32.11	2.62	4.97%	18.89%
HSIC	9.0B	12.3B	-5.34%	-15.09%	21.69	0.73	-2.44%	-22.68%
BIO	8.5B	2.7B	-12.68%	-39.24%	-13.34	3.18	-4.68%	82.43%
XRAY	6.3B	4.0B	-7.94%	-25.15%	-46.81	1.59	1.10%	85.84%
AXNX	3.4B	366.4M	-1.55%	17.10%	-564.66	9.35	33.86%	89.83%
PDCO	2.3B	6.6B	-3.92%	-2.28%	11.91	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-5.32%	-19.06%	-1.85	0.39	7.73%	-1066.14%
ANIK	382.1M	166.7M	1.82%	-7.51%	-4.62	2.29	6.67%	-456.34%
ANGO	253.5M	324.0M	17.44%	-27.90%	-1.32	0.78	-3.19%	-337.41%
APYX	45.7M	52.3M	-25.42%	-56.00%	-2.44	0.87	17.61%	19.28%
AEMD	3.7M	3.7M	-14.97%	255.00%	-0.3	0.99	5.77%	8.23%

Cardinal Health Inc News

Latest updates

Cardinal Health Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	4.9%	57,445	54,763	53,453	50,487	51,469	49,603	47,103	44,836	45,457	43,968	42,586	39,275	41,541	39,065	36,689	39,157	39,735	37,341	37,353	35,228	37,740
Gross Profit	4.4%	1,846	1,768	1,827	1,785	1,663	1,614	1,605	1,682	1,616	1,642	1,475	1,812	1,776	1,715	1,590	1,885	1,714	1,679	1,674	1,764	1,730
S&GA Expenses	7.2%	1,283	1,197	1,267	1,179	1,191	1,197	1,155	1,137	1,151	1,114	1,129	1,120	1,147	1,137	1,137	1,165	1,163	1,107	1,168	1,097	1,064
EBITDA Margin	44.1%	0.01*	0.01*	0.01*	0.01*	0.00*	0.00*	0.00*	0.00*	0.00*	0.01*	0.01*	0.01*	-	-	-	-	-	-	-	-	-
Interest Expenses	-42.9%	8.00	14.00	15.00	28.00	25.00	25.00	34.00	38.00	37.00	40.00	44.00	45.00	46.00	45.00	49.00	60.00	63.00	66.00	67.00	75.00	76.00
Income Taxes	525.0%	136	-32.00	187	197	-7.00	-1.00	-165	1,253	-1,022	97.00	4.00	320	-203	-410	107	-127	-59.00	-423	44.00	74.00	126
Earnings Before Taxes	1984.6%	490	-26.00	121	544	-137	110	-28.00	-137	-973	369	119	440	427	-663	815	478	279	-5,344	239	370	407
EBT Margin	118.6%	0.01*	0.00*	0.00*	0.00*	0.00*	-0.01*	0.00*	0.00*	0.00*	0.01*	0.00*	0.01*	-	-	-	-	-	-	-	-	-
Net Income	6960.0%	353	5.00	-64.00	345	-130	110	138	-1,391	49.00	271	116	119	629	-253	656	350	220	-4,922	194	296	280
Net Income Margin	298.4%	0.00*	0.00*	0.00*	0.00*	-0.01*	-0.01*	-0.01*	-0.01*	0.00*	0.01*	0.00*	0.01*	-	-	-	-	-	-	-	-	-
Free Cashflow	137.3%	1,075	453	641	1,252	512	-47.00	2,828	-501	1,121	-713	539	177	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	6.5%	46,573	43,710	43,417	43,377	44,482	43,387	43,878	42,111	43,680	42,993	44,453	43,874	44,719	41,727	40,766	41,148	41,042	39,179	40,963	40,809	40,462
Current Assets	8.6%	37,658	34,688	33,833	33,497	34,596	32,696	32,935	30,884	31,847	29,731	31,048	30,362	30,113	27,030	25,940	25,848	25,736	23,715	25,747	25,582	25,091
Cash Equivalents	19.1%	4,591	3,854	4,043	3,990	3,654	3,492	4,717	2,356	3,161	2,463	3,407	3,499	3,737	2,746	2,771	2,329	1,659	1,212	2,531	3,438	2,182
Inventory	8.6%	18,451	16,987	15,940	16,620	17,263	15,891	15,636	15,493	14,941	14,720	14,594	14,329	14,443	13,439	13,198	12,808	13,799	12,458	12,822	12,622	13,037
Net PPE	0.2%	2,446	2,441	2,462	2,362	2,341	2,339	2,361	2,298	2,321	2,336	2,360	2,315	2,386	2,369	2,366	2,299	2,301	2,324	2,356	2,322	2,376
Current Liabilities	9.2%	38,286	35,065	33,706	32,503	33,212	31,559	30,550	28,715	27,729	26,499	27,624	25,323	25,750	24,016	23,615	24,671	24,890	22,549	24,109	23,919	23,824
Long Term Debt	-9.1%	3,535	3,890	3,909	4,708	4,685	4,689	4,735	4,751	5,342	5,353	5,365	6,715	6,720	6,728	6,765	6,754	6,742	7,360	7,579	7,629	7,599
Shareholder's Equity	-	-	-	-	-	-	-	-	-	1,002	1,396	1,794	1,794	1,975	1,425	1,792	1,206	1,002	903	6,330	6,232	6,043
Retained Earnings	35.0%	-425	-654	-534	-342	-560	-301	-280	-281	1,245	1,335	1,205	1,233	1,255	771	1,170	656	449	371	5,434	5,386	5,233
Shares Outstanding	-0.8%	247	249	261	256	261	271	279	281	283	287	292	292	-	-	-	-	-	-	-	-	-
Minority Interest	100.0%	2.00	1.00	1.00	2.00	1.00	1.00	3.00	4.00	4.00	3.00	3.00	4.00	4.00	3.00	3.00	3.00	3.00	3.00	2.00	2.00	-
Float	-	-	-	-	-	19,775	-	-	-	14,224	-	-	-	15,694	-	-	-	14,729	-	-	-	13,268

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	118.2%	1,189	545	858	1,361	597	23.00	2,992	-419	1,195	-646	665	277	1,217	270	240	1,676	697	-653	506	1,480	371
Share Based Compensation	-3.4%	28.00	29.00	27.00	21.00	25.00	23.00	16.00	23.00	18.00	24.00	5.00	33.00	23.00	28.00	22.00	27.00	21.00	20.00	18.00	23.00	22.00
Cashflow From Investing	-66.7%	-105	-63.00	-206	-91.00	-87.00	-70.00	-204	-44.00	-47.00	862	-88.00	-99.00	-97.00	-94.00	742	-98.00	-78.00	-73.00	-173	-84.00	-84.00
Cashflow From Financing	47.0%	-353	-666	-592	-934	-362	-1,163	-415	-340	-444	-1,264	-649	-324	-146	-198	-528	-912	-175	-585	-1,243	-142	-144
Dividend Payments	-5.3%	124	131	126	128	129	142	134	136	140	149	141	143	143	146	141	141	141	146	142	142	143
Buy Backs	-80.0%	100	500	650	50.00	150	1,000	220	20.00	40.00	500	-	200	-	-	-	-35.00	70.00	350	-	-	-

CAH Income Statement

2023-12-31

Condensed Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenue	$ 57,445	$ 51,469	$ 112,208	$ 101,072
Cost of products sold	55,599	49,806	108,594	97,795
Gross margin	1,846	1,663	3,614	3,277
Operating expenses:
Distribution, selling, general and administrative expenses	1,283	1,191	2,480	2,388
Restructuring and employee severance	28	17	53	46
Amortization and other acquisition-related costs	63	71	127	142
Impairments and (gain)/loss on disposal of assets, net	1	710	538	863
Litigation (recoveries)/charges, net	(11)	(207)	(52)	(180)
Operating earnings/(loss)	482	(119)	468	18
Other (income)/expense, net	(16)	(7)	(18)	(5)
Interest expense, net	8	25	22	50
Earnings/(loss) before income taxes	490	(137)	464	(27)
Provision for/(benefit from) income taxes	136	(7)	104	(8)
Net earnings/(loss)	354	(130)	360	(19)
Less: Net earnings attributable to noncontrolling interests	(1)	0	(2)	(1)
Net earnings/(loss) attributable to Cardinal Health, Inc.	$ 353	$ (130)	$ 358	$ (20)
Earnings/(Loss) per common share attributable to Cardinal Health, Inc.:
Basic (in shares)	$ 1.44	$ (0.50)	$ 1.45	$ (0.08)
Diluted (in shares)	$ 1.43	$ (0.50)	$ 1.44	$ (0.08)
Weighted-average number of common shares outstanding:
Basic (in shares)	245	261	247	266
Diluted (in shares)	246	261	248	266
Cash dividends declared per common share	$ 0.5006	$ 0.4957	$ 1.0012	$ 0.9914

CAH Balance Sheet

2023-12-31

Condensed Consolidated Balance Sheets - USD ($) shares in Thousands, $ in Millions	Dec. 31, 2023	Jun. 30, 2023
Current assets:
Cash and equivalents	$ 4,591	$ 4,043
Trade receivables, net	11,788	11,344
Inventories, net	18,451	15,940
Prepaid expenses and other	2,816	2,362
Assets held for sale	12	144
Total current assets	37,658	33,833
Property and equipment, net	2,446	2,462
Goodwill and other intangibles, net	5,371	6,081
Other assets	1,098	1,041
Total assets	46,573	43,417
Current liabilities:
Accounts payable	34,259	29,813
Current portion of long-term obligations and other short-term borrowings	1,188	792
Other accrued liabilities	2,839	3,059
Liabilities related to assets held for sale	0	42
Total current liabilities	38,286	33,706
Long-term obligations, less current portion	3,535	3,909
Deferred income taxes and other liabilities	8,199	8,653
Preferred shares, without par value:
Authorized—500 thousand shares, Issued—none	$ 0	$ 0
Preferred shares, authorized	500	500
Preferred shares, issued	0	0
Common shares, without par value:
Authorized—755 million shares, Issued—327 million shares at December 31, 2023 and June 30, 2023	$ 2,855	$ 2,747
Common shares, authorized	755,000	755,000
Common shares, issued	327,000	327,000
Accumulated deficit	$ (425)	$ (534)
Common shares in treasury, at cost: 83 million shares and 76 million shares at December 31, 2023 and June 30, 2023, respectively	$ (5,724)	$ (4,914)
Common shares in treasury	83,000	76,000
Accumulated other comprehensive loss	$ (155)	$ (151)
Total Cardinal Health, Inc. shareholders' deficit	(3,449)	(2,852)
Noncontrolling interests	2	1
Total shareholders’ deficit	(3,447)	(2,851)
Total liabilities and shareholders’ deficit	$ 46,573	$ 43,417

About Cardinal Health Inc

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

CEO	Mr. Jason M. Hollar
WEBSITE	cardinalhealth.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	47040

Cardinal Health Inc Frequently Asked Questions

What is the ticker symbol for Cardinal Health Inc? What does CAH stand for in stocks?

CAH is the stock ticker symbol of Cardinal Health Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Cardinal Health Inc (CAH)?

As of Wed Apr 17 2024, market cap of Cardinal Health Inc is 25.9 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CAH stock?

You can check CAH's fair value in chart for subscribers.

What is the fair value of CAH stock?

You can check CAH's fair value in chart for subscribers. The fair value of Cardinal Health Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Cardinal Health Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CAH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Cardinal Health Inc a good stock to buy?

The fair value guage provides a quick view whether CAH is over valued or under valued. Whether Cardinal Health Inc is cheap or expensive depends on the assumptions which impact Cardinal Health Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CAH.

What is Cardinal Health Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 17 2024, CAH's PE ratio (Price to Earnings) is 40.53 and Price to Sales (PS) ratio is 0.12. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CAH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Cardinal Health Inc's stock?

In the past 10 years, Cardinal Health Inc has provided 0.073 (multiply by 100 for percentage) rate of return.